Joel Greenblatt's XERS Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 123,914 shares of Xeris Biopharma Holdings, Inc. (XERS) worth $981,399, representing 0.00% of the portfolio. First purchased in 2025-Q1, this short-term holding has been held for 6 quarters.
Based on 13F filings, Joel Greenblatt has maintained this position in XERS for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2026, adding 80,657 shares. Largest reduction occurred in Q4 2025, reducing 7,329 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Xeris Biopharma Holdings (XERS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Xeris Biopharma Holdings (XERS) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +80,657 | Add 186.46% | 123,914 | $7.92 |
| Q1 2026 | +7,845 | Add 22.15% | 43,257 | $5.80 |
| Q4 2025 | -7,329 | Reduce 17.15% | 35,412 | $7.85 |
| Q3 2025 | +9,975 | Add 30.44% | 42,741 | $8.14 |
| Q2 2025 | +16,534 | Add 101.86% | 32,766 | $4.67 |
| Q1 2025 | +16,232 | New Buy | 16,232 | $5.49 |
Joel Greenblatt's Xeris Biopharma Holdings Investment FAQs
Joel Greenblatt first purchased Xeris Biopharma Holdings, Inc. (XERS) in Q1 2025, acquiring 16,232 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Xeris Biopharma Holdings, Inc. (XERS) for 6 quarters since Q1 2025.
Joel Greenblatt's largest addition to Xeris Biopharma Holdings, Inc. (XERS) was in Q2 2026, adding 123,914 shares worth $981,399.
According to the latest 13F filing for Q2 2026, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 123,914 shares of Xeris Biopharma Holdings, Inc. (XERS), valued at approximately $981,399.
As of the Q2 2026 filing, Xeris Biopharma Holdings, Inc. (XERS) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Xeris Biopharma Holdings, Inc. (XERS) was 123,914 shares, as reported at the end of Q2 2026.